Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

Also called NCT06440694

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06440694
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06440694. Randomized; quadruple masking; primary purpose treatment. Start 2025-07-07 (actual); primary completion 2027-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)
Condition
Venous Thromboembolism
Intervention (Drug)
Colchicine 0.5 mg po
Intervention (Drug)
Placebo 0.5 mg po
Lead sponsor
Ottawa Hospital Research Institute (class: other)

Record details

Record id
cardio:ct-nct06440694
Content hash
831a38f90910019da0df93d0d9a5adec0a16650c8936eee020aa34b7ec210453